Phase I/II dose-escalating study of bi-weekly ALIMTA [pemetrexed] and fixed dose rate Gemzar [gemcitabine] in patients with advanced pancreatic and biliary tract cancer
Phase of Trial: Phase I/II
Latest Information Update: 13 Feb 2006
At a glance
- Drugs Gemcitabine; Pemetrexed
- Indications Biliary cancer; Pancreatic cancer
- Focus Therapeutic Use
- 13 Feb 2006 New trial record.